[
  {
    "title": "赛升药业(300485.SZ)：拟以664.64万元转让中润伟业45%股权",
    "href": "http://stock.jrj.com.cn/2023/01/06163337264409.shtml",
    "datetime": "2023-01-06 16:33:17",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：赛而生物与海晶生物签署技术合作开发合同",
    "href": "http://stock.jrj.com.cn/2022/12/29203937247616.shtml",
    "datetime": "2022-12-29 20:39:41",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：单唾液酸四己糖神经节苷脂钠注射液申请获受理",
    "href": "http://stock.jrj.com.cn/2022/12/27162537240625.shtml",
    "datetime": "2022-12-27 16:25:45",
    "code": "300485"
  },
  {
    "title": "赛升药业：参股公司康乐卫士IPO获北交所审核通过",
    "href": "http://stock.jrj.com.cn/2022/12/25204837236603.shtml",
    "datetime": "2022-12-25 20:48:13",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：参股公司康乐卫士北交所IPO成功过会",
    "href": "http://stock.jrj.com.cn/2022/12/25162437236392.shtml",
    "datetime": "2022-12-25 16:24:46",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：子公司君元药业药品生产许可证变更",
    "href": "http://stock.jrj.com.cn/2022/12/05155537188746.shtml",
    "datetime": "2022-12-05 15:55:38",
    "code": "300485"
  },
  {
    "title": "赛升药业：子公司君元药业通过药品GMP现场符合性检查 相关剂型产品可投入生产",
    "href": "http://stock.jrj.com.cn/2022/11/23141837160457.shtml",
    "datetime": "2022-11-23 14:18:58",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：子公司君元药业通过药品GMP现场符合性检查",
    "href": "http://stock.jrj.com.cn/2022/11/23114637160100.shtml",
    "datetime": "2022-11-23 11:46:22",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：绿竹生物首次公开发行境外上市外资股及境内未上市股份全流通申请获证监会核准批复",
    "href": "http://stock.jrj.com.cn/2022/11/21172937154681.shtml",
    "datetime": "2022-11-21 17:29:53",
    "code": "300485"
  },
  {
    "title": "赛升药业2022年前三季度净利2.53亿同比增长83.44% 本期定期存款利息减少",
    "href": "http://stock.jrj.com.cn/2022/10/25201137082997.shtml",
    "datetime": "2022-10-25 20:11:48",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：第三季度净利1844.35万元，同比下降64.79%",
    "href": "http://stock.jrj.com.cn/2022/10/25171937082030.shtml",
    "datetime": "2022-10-25 17:19:47",
    "code": "300485"
  },
  {
    "title": "赛升药业：收到人源化抗VEGF单抗注射液补充申请受理通知书",
    "href": "http://stock.jrj.com.cn/2022/09/26155237021544.shtml",
    "datetime": "2022-09-26 15:52:29",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：赛创投资基金以720万元受让海晶生物18%的股权",
    "href": "http://stock.jrj.com.cn/2022/08/09174136883495.shtml",
    "datetime": "2022-08-09 17:41:20",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：拟以1000万元与赛盈私募共设赛创投资基金",
    "href": "http://stock.jrj.com.cn/2022/07/13205336808902.shtml",
    "datetime": "2022-07-13 20:53:57",
    "code": "300485"
  },
  {
    "title": "赛升药业2022年半年预计净利2.13亿-2.47亿同比增长150%-190% 联营企业投资收益增加",
    "href": "http://stock.jrj.com.cn/2022/07/13201036808675.shtml",
    "datetime": "2022-07-13 20:10:48",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)半年度扣非净利润预降20%-50%",
    "href": "http://stock.jrj.com.cn/2022/07/13170936807752.shtml",
    "datetime": "2022-07-13 17:09:45",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：控股子公司赛而生物收到行政处罚",
    "href": "http://stock.jrj.com.cn/2022/07/10163136796961.shtml",
    "datetime": "2022-07-10 16:31:07",
    "code": "300485"
  },
  {
    "title": "赛升药业拟投资1亿设立全资子公司吉林省安牛牧业生物科技有限公司",
    "href": "http://stock.jrj.com.cn/2022/05/12193236643958.shtml",
    "datetime": "2022-05-12 19:32:56",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：拟以1亿元设安牛牧业生物科技",
    "href": "http://stock.jrj.com.cn/2022/05/12155736642885.shtml",
    "datetime": "2022-05-12 15:57:21",
    "code": "300485"
  },
  {
    "title": "赛升药业2022年第一季度预计净利1.02亿-1.15亿 同比增加140%-170%联营企业收益增加",
    "href": "http://stock.jrj.com.cn/2022/04/12183036316258.shtml",
    "datetime": "2022-04-12 18:30:48",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)一季度扣非净利润预降10%-40%",
    "href": "http://stock.jrj.com.cn/2022/04/12160836315225.shtml",
    "datetime": "2022-04-12 16:08:04",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：未能竞拍获得北京益而康生物工程51%股权项目",
    "href": "http://stock.jrj.com.cn/2022/04/08154636272655.shtml",
    "datetime": "2022-04-08 15:46:38",
    "code": "300485"
  },
  {
    "title": "赛升药业2021年净利4.02亿同比增长159.69% 董事长马骉薪酬54.06万",
    "href": "http://stock.jrj.com.cn/2022/03/30203136205119.shtml",
    "datetime": "2022-03-30 20:31:54",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)2021年度净利润升159.69%至4.02亿元 拟10派1.68元",
    "href": "http://stock.jrj.com.cn/2022/03/30174436199688.shtml",
    "datetime": "2022-03-30 17:44:51",
    "code": "300485"
  },
  {
    "title": "A股异动 | 赛升药业(300485.SZ)涨近6% 子公司君元药业通过药品GMP现场符合性检查",
    "href": "http://stock.jrj.com.cn/2022/03/29134136117733.shtml",
    "datetime": "2022-03-29 13:41:27",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：子公司君元药业通过药品GMP现场符合性检查",
    "href": "http://stock.jrj.com.cn/2022/03/29114436097309.shtml",
    "datetime": "2022-03-29 11:44:03",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：君元药业变更药品生产许可证",
    "href": "http://stock.jrj.com.cn/2022/03/21160734855790.shtml",
    "datetime": "2022-03-21 16:07:25",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：拟出售北京市丰台区的相关房产",
    "href": "http://stock.jrj.com.cn/2022/03/21160534855784.shtml",
    "datetime": "2022-03-21 16:05:37",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：注射用葛根素和肌氨肽苷注射液增加生产场地",
    "href": "http://stock.jrj.com.cn/2022/03/10163934808972.shtml",
    "datetime": "2022-03-10 16:39:27",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：通过药品GMP现场符合性检查",
    "href": "http://stock.jrj.com.cn/2022/03/10163734808961.shtml",
    "datetime": "2022-03-10 16:37:47",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：子公司三个剂型生产线通过药品GMP现场符合性检查",
    "href": "http://stock.jrj.com.cn/2022/02/07161734301803.shtml",
    "datetime": "2022-02-07 16:17:36",
    "code": "300485"
  },
  {
    "title": "赛升药业净利润预增 结束三年业绩“连降”研发投入占比年年攀升",
    "href": "http://stock.jrj.com.cn/2022/01/26090834222206.shtml",
    "datetime": "2022-01-26 09:08:00",
    "code": "300485"
  },
  {
    "title": "赛升药业2021年预计净利3.56亿-4.03亿同比增长130%-160% 确认联营企业投资收益",
    "href": "http://stock.jrj.com.cn/2022/01/25195134213739.shtml",
    "datetime": "2022-01-25 19:51:16",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)2021年度净利润预增130%-160%",
    "href": "http://stock.jrj.com.cn/2022/01/25172734212781.shtml",
    "datetime": "2022-01-25 17:27:20",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：收到政府补助654万元",
    "href": "http://stock.jrj.com.cn/2021/12/31161634093226.shtml",
    "datetime": "2021-12-31 16:16:00",
    "code": "300485"
  },
  {
    "title": "赛升药业“注射用甲磺酸萘莫司他”药品注册获受理",
    "href": "http://stock.jrj.com.cn/2021/12/16135334024051.shtml",
    "datetime": "2021-12-16 13:53:00",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：注射用甲磺酸萘莫司他药品注册申请获受理",
    "href": "http://stock.jrj.com.cn/2021/12/16115634023763.shtml",
    "datetime": "2021-12-16 11:56:11",
    "code": "300485"
  },
  {
    "title": "赛升药业440万元向个人出售北京南三环嘉业大厦房产：建筑面积130.34平方米",
    "href": "http://stock.jrj.com.cn/2021/12/03175233960791.shtml",
    "datetime": "2021-12-03 17:52:38",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：持股5%以上股东马丽减持股份达2.55%",
    "href": "http://stock.jrj.com.cn/2021/11/22155133903913.shtml",
    "datetime": "2021-11-22 15:51:58",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：前三季度扣非净利润降22.32%至8732.66万元",
    "href": "http://stock.jrj.com.cn/2021/10/27161233761584.shtml",
    "datetime": "2021-10-27 16:12:16",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：拟与华放天实签署K11项目临床期间药学研究及BLA申报服务合同",
    "href": "http://stock.jrj.com.cn/2021/09/10160833415421.shtml",
    "datetime": "2021-09-10 16:08:30",
    "code": "300485"
  },
  {
    "title": "赛升药业：拟与华放天实签署《K11项目临床期间药学研究及BLA申报服务合同》",
    "href": "http://stock.jrj.com.cn/2021/09/10160633415414.shtml",
    "datetime": "2021-09-10 16:06:54",
    "code": "300485"
  },
  {
    "title": "赛升药业2021年半年度净利8533.35万元 同比净利增加0.53%",
    "href": "http://stock.jrj.com.cn/2021/08/26200133326429.shtml",
    "datetime": "2021-08-26 20:01:35",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)获得知识产权管理体系证书",
    "href": "http://stock.jrj.com.cn/2021/08/16161733260694.shtml",
    "datetime": "2021-08-16 16:17:20",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：子公司赛而生物药品生产许可证变更",
    "href": "http://stock.jrj.com.cn/2021/08/13204733250623.shtml",
    "datetime": "2021-08-13 20:47:34",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：公司药品生产许可证变更",
    "href": "http://stock.jrj.com.cn/2021/08/13204533250572.shtml",
    "datetime": "2021-08-13 20:45:27",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：参股公司绿竹生物重组带状疱疹疫苗获批临床",
    "href": "http://stock.jrj.com.cn/2021/08/05115633206144.shtml",
    "datetime": "2021-08-05 11:56:29",
    "code": "300485"
  },
  {
    "title": "赛升药业：为子公司中润伟业向银行申请综合授信额度提供不超8000万元担保",
    "href": "http://stock.jrj.com.cn/2021/06/30155633022072.shtml",
    "datetime": "2021-06-30 15:56:40",
    "code": "300485"
  },
  {
    "title": "赛升药业：公司对引入战略投资者一直持开放态度",
    "href": "http://stock.jrj.com.cn/2021/06/24191732991051.shtml",
    "datetime": "2021-06-24 19:17:25",
    "code": "300485"
  },
  {
    "title": "赛升药业：公司副总经理兼财务总监马丽女士持有北京奥唯康健生物科技有限公司80%的股份",
    "href": "http://stock.jrj.com.cn/2021/06/24191732991053.shtml",
    "datetime": "2021-06-24 19:17:20",
    "code": "300485"
  },
  {
    "title": "赛升药业：为盘活公司现有资产 拟660万元出售部分闲置房产",
    "href": "http://stock.jrj.com.cn/2021/05/25144532816338.shtml",
    "datetime": "2021-05-25 14:45:42",
    "code": "300485"
  },
  {
    "title": "A股异动 | 赛升药业(300485.SZ)涨9.8% 拟660万元出售闲置资产",
    "href": "http://stock.jrj.com.cn/2021/05/25134132816115.shtml",
    "datetime": "2021-05-25 13:41:58",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：660万元出售北京丰台闲置房产 获利212.67万元",
    "href": "http://stock.jrj.com.cn/2021/05/25115632815808.shtml",
    "datetime": "2021-05-25 11:56:10",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：以600万元认购拜西欧斯注册资本",
    "href": "http://stock.jrj.com.cn/2021/05/17161532769386.shtml",
    "datetime": "2021-05-17 16:15:44",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：一季度净利4240.99万元 同比增长66.68%",
    "href": "http://stock.jrj.com.cn/2021/04/28162932472002.shtml",
    "datetime": "2021-04-28 16:29:20",
    "code": "300485"
  },
  {
    "title": "赛升药业：子公司君元药业取得《药品生产许可证》 从长期看将对其生产经营产生积极作用",
    "href": "http://stock.jrj.com.cn/2021/04/19143232401602.shtml",
    "datetime": "2021-04-19 14:32:48",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：子公司君元药业取得药品生产许可证",
    "href": "http://stock.jrj.com.cn/2021/04/19115632400668.shtml",
    "datetime": "2021-04-19 11:56:57",
    "code": "300485"
  },
  {
    "title": "赛升药业2021年第一季度预计净利增长50%-80% 销售收入增长",
    "href": "http://stock.jrj.com.cn/2021/04/06214132320896.shtml",
    "datetime": "2021-04-06 21:41:34",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)一季度净利润预增50%-80%",
    "href": "http://stock.jrj.com.cn/2021/04/06181332320124.shtml",
    "datetime": "2021-04-06 18:13:09",
    "code": "300485"
  },
  {
    "title": "赛升药业：君元药业正积极实施生产建设",
    "href": "http://stock.jrj.com.cn/2021/04/06084532317174.shtml",
    "datetime": "2021-04-06 08:45:45",
    "code": "300485"
  },
  {
    "title": "赛升药业2020年净利增长4.21% 董事长马骉薪酬47.36万",
    "href": "http://stock.jrj.com.cn/2021/03/30093032246177.shtml",
    "datetime": "2021-03-30 09:30:26",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)2020年度净利润升4.21%至1.55亿元 拟10派0.65元",
    "href": "http://stock.jrj.com.cn/2021/03/29205832243251.shtml",
    "datetime": "2021-03-29 20:58:37",
    "code": "300485"
  },
  {
    "title": "赛升药业2020年度净利1.5亿 比上年同期增长0.76%",
    "href": "http://stock.jrj.com.cn/2021/03/05205832080256.shtml",
    "datetime": "2021-03-05 20:58:03",
    "code": "300485"
  },
  {
    "title": "赛升药业业绩快报：2020年实现归母净利润1.5亿元 同比微增0.76%",
    "href": "http://stock.jrj.com.cn/2021/03/05143532078055.shtml",
    "datetime": "2021-03-05 14:35:14",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)业绩快报：2020年净利微增0.76%至1.50亿元",
    "href": "http://stock.jrj.com.cn/2021/03/05114732077365.shtml",
    "datetime": "2021-03-05 11:47:58",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)拟与生物医药二期受让绿竹生物15.385%股权",
    "href": "http://stock.jrj.com.cn/2021/02/22180232006972.shtml",
    "datetime": "2021-02-22 18:02:01",
    "code": "300485"
  },
  {
    "title": "赛升药业：与中润伟业投资有限公司合作有利于为公司开发新的业务领域",
    "href": "http://stock.jrj.com.cn/2021/01/08164131655873.shtml",
    "datetime": "2021-01-08 16:41:55",
    "code": "300485"
  },
  {
    "title": "赛升药业2名股东合计减持1284.5万股 套现合计约1.98亿元",
    "href": "http://stock.jrj.com.cn/2021/01/07190631649620.shtml",
    "datetime": "2021-01-07 19:06:24",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：马丽及一致行动人减持期届满 合计减持291.6万股",
    "href": "http://stock.jrj.com.cn/2021/01/07163031648381.shtml",
    "datetime": "2021-01-07 16:30:11",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)通过国家高新技术企业重新认定",
    "href": "http://stock.jrj.com.cn/2020/12/30170031605327.shtml",
    "datetime": "2020-12-30 17:00:21",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：664.64万元成功拍得中润伟业45%股权",
    "href": "http://stock.jrj.com.cn/2020/12/29165331595924.shtml",
    "datetime": "2020-12-29 16:53:58",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：持股5%以上股东马丽减持1.43%股份",
    "href": "http://stock.jrj.com.cn/2020/12/15173731495320.shtml",
    "datetime": "2020-12-15 17:37:38",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)：控股子公司取得换发《药品生产许可证》",
    "href": "http://stock.jrj.com.cn/2020/12/14154831487210.shtml",
    "datetime": "2020-12-14 15:48:14",
    "code": "300485"
  },
  {
    "title": "赛升药业(300485.SZ)取得换发《药品生产许可证》",
    "href": "http://stock.jrj.com.cn/2020/12/09172931450050.shtml",
    "datetime": "2020-12-09 17:29:29",
    "code": "300485"
  },
  {
    "title": "赛升药业：公司暂不涉及新冠疫苗领域",
    "href": "http://stock.jrj.com.cn/2020/12/01143731384436.shtml",
    "datetime": "2020-12-01 14:37:03",
    "code": "300485"
  },
  {
    "title": "赛升药业：目前GGE-3项目处于成药性评价阶段",
    "href": "http://stock.jrj.com.cn/2020/12/01143331384428.shtml",
    "datetime": "2020-12-01 14:33:38",
    "code": "300485"
  },
  {
    "title": "赛升药业：生物医药二期基金已有合适的投资标的尽调中重点投资领域为新一代健康诊疗与服务行业等",
    "href": "http://stock.jrj.com.cn/2020/12/01143331384429.shtml",
    "datetime": "2020-12-01 14:33:33",
    "code": "300485"
  },
  {
    "title": "赛升药业：医药生产基地项目和心脑血管及免疫调节产品产业化项目正在进行产品验证工作",
    "href": "http://stock.jrj.com.cn/2020/11/12172631268530.shtml",
    "datetime": "2020-11-12 17:26:12",
    "code": "300485"
  },
  {
    "title": "赛升药业：虽然受疫情影响，但君元药业将积极按年初制定的目标实施生产建",
    "href": "http://stock.jrj.com.cn/2020/11/10150331251003.shtml",
    "datetime": "2020-11-10 15:03:55",
    "code": "300485"
  },
  {
    "title": "赛升药业2020年前三季度净利1.29亿增长1.92% 其他收益同比增长",
    "href": "http://stock.jrj.com.cn/2020/10/28153531150794.shtml",
    "datetime": "2020-10-28 15:35:32",
    "code": "300485"
  },
  {
    "title": "赛升药业：康乐卫士为公司投资并购基金所投项目",
    "href": "http://stock.jrj.com.cn/2020/10/23151731116279.shtml",
    "datetime": "2020-10-23 15:17:31",
    "code": "300485"
  },
  {
    "title": "赛升药业高级管理人员孔双泉合计减持2万股 套现约43万元",
    "href": "http://stock.jrj.com.cn/2020/09/07205530695367.shtml",
    "datetime": "2020-09-07 20:55:42",
    "code": "300485"
  },
  {
    "title": "生物疫苗概念午后大幅拉升 万泰生物、一心堂、赛升药业等多股大涨",
    "href": "http://stock.jrj.com.cn/2020/08/28134230613610.shtml",
    "datetime": "2020-08-28 13:42:48",
    "code": "300485"
  },
  {
    "title": "赛升药业2020年上半年净利8488.45万 同比减少9%",
    "href": "http://stock.jrj.com.cn/2020/08/27183130605794.shtml",
    "datetime": "2020-08-27 18:31:33",
    "code": "300485"
  },
  {
    "title": "赛升药业：绿竹生物的重组带状疱疹病毒疫苗正在研发中",
    "href": "http://stock.jrj.com.cn/2020/07/30144130384708.shtml",
    "datetime": "2020-07-30 14:41:55",
    "code": "300485"
  },
  {
    "title": "生物疫苗概念走强 复星医药、康华生物、赛升药业涨停",
    "href": "http://stock.jrj.com.cn/2020/07/27134230354137.shtml",
    "datetime": "2020-07-27 13:42:38",
    "code": "300485"
  },
  {
    "title": "【龙虎榜】赛升药业7月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/17180230275458.shtml",
    "datetime": "2020-07-17 18:02:13",
    "code": "300485"
  },
  {
    "title": "快讯：赛升药业急速拉升5.35% 主力资金净流入358.82万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/07100030163373.shtml",
    "datetime": "2020-07-07 10:00:03",
    "code": "300485"
  },
  {
    "title": "快讯：赛升药业急速拉升5.13% 主力资金净流出818.71万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/29093930083752.shtml",
    "datetime": "2020-06-29 09:39:00",
    "code": "300485"
  },
  {
    "title": "【公告解读】赛升药业：公司药品获得伦理委员会审查批件",
    "href": "http://stock.jrj.com.cn/2020/06/18225629960007.shtml",
    "datetime": "2020-06-18 22:56:58",
    "code": "300485"
  },
  {
    "title": "赛升药业大股东“精准”减持1600万股 “重营销轻研发”恶果仍在消化",
    "href": "http://stock.jrj.com.cn/2020/06/17082129947186.shtml",
    "datetime": "2020-06-17 08:21:00",
    "code": "300485"
  },
  {
    "title": "四连板后 赛升药业三股东欲组团减持",
    "href": "http://stock.jrj.com.cn/2020/06/17014929941981.shtml",
    "datetime": "2020-06-17 01:49:09",
    "code": "300485"
  },
  {
    "title": "【公告解读】赛升药业：股东及高管拟合计减持不超3.4%股份",
    "href": "http://stock.jrj.com.cn/2020/06/16173829939393.shtml",
    "datetime": "2020-06-16 17:38:37",
    "code": "300485"
  },
  {
    "title": "四连板赛升药业：高管马丽、刘淑芹与孔双泉拟减持不超过总股本的3.4017%",
    "href": "http://stock.jrj.com.cn/2020/06/16171629939234.shtml",
    "datetime": "2020-06-16 17:16:57",
    "code": "300485"
  },
  {
    "title": "赛升药业一字涨停 互动平台吹风病毒抗体概念成正果",
    "href": "http://stock.jrj.com.cn/2020/06/15101229925202.shtml",
    "datetime": "2020-06-15 10:12:00",
    "code": "300485"
  },
  {
    "title": "赛升药业隔山打牛疫苗封涨停 业绩常下跌机构常卖出",
    "href": "http://stock.jrj.com.cn/2020/05/25113629758820.shtml",
    "datetime": "2020-05-25 11:36:00",
    "code": "300485"
  },
  {
    "title": "生物疫苗板块走强 赛升药业涨停",
    "href": "http://stock.jrj.com.cn/2020/05/25093429757399.shtml",
    "datetime": "2020-05-25 09:34:49",
    "code": "300485"
  },
  {
    "title": "赛升药业屡扇风病毒抗体概念吃跌停 是否忽悠投资者",
    "href": "http://stock.jrj.com.cn/2020/05/18155629702856.shtml",
    "datetime": "2020-05-18 15:56:00",
    "code": "300485"
  },
  {
    "title": "【龙虎榜】赛升药业5月14日成交明细(dev)",
    "href": "http://stock.jrj.com.cn/2020/05/14180229672931.shtml",
    "datetime": "2020-05-14 18:02:40",
    "code": "300485"
  },
  {
    "title": "赛升药业第一季度盈利2544.36万同比减少43.19% 销售收入减少",
    "href": "http://stock.jrj.com.cn/2020/04/29145429418987.shtml",
    "datetime": "2020-04-29 14:54:41",
    "code": "300485"
  },
  {
    "title": "赛升药业：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/10084029253706.shtml",
    "datetime": "2020-04-10 08:40:08",
    "code": "300485"
  },
  {
    "title": "赛升药业2020年第一季度预计净利2239.21万元-3134.89万元 同比下降30%-50%",
    "href": "http://stock.jrj.com.cn/2020/04/10002029250658.shtml",
    "datetime": "2020-04-10 00:20:20",
    "code": "300485"
  },
  {
    "title": "[互动]赛升药业：目前整体的复工率达到86%以上",
    "href": "http://stock.jrj.com.cn/2020/03/18145629052271.shtml",
    "datetime": "2020-03-18 14:56:44",
    "code": "300485"
  },
  {
    "title": "赛升药业2019年净利润1.51亿元减少46.67% 研发投入持续增长",
    "href": "http://stock.jrj.com.cn/2020/02/28175728915809.shtml",
    "datetime": "2020-02-28 17:57:13",
    "code": "300485"
  },
  {
    "title": "赛升药业：公司并购基金所投企业正开发预防新冠病毒的疫苗",
    "href": "http://stock.jrj.com.cn/2020/02/20141628861908.shtml",
    "datetime": "2020-02-20 14:16:00",
    "code": "300485"
  },
  {
    "title": "赛升药业：天广实公司正与军事医学科学院研发治疗性2019-nCov单克隆抗体",
    "href": "http://stock.jrj.com.cn/2020/02/04111328765455.shtml",
    "datetime": "2020-02-04 11:13:06",
    "code": "300485"
  },
  {
    "title": "[赛升药业]驰援湖北,共同抗\"疫” ----赛升药业在行动",
    "href": "http://stock.jrj.com.cn/2020/02/03000028755299.shtml",
    "datetime": "2020-02-03 00:00:00",
    "code": "300485"
  },
  {
    "title": "[赛升药业]赛升药业荣登“2019年中国上市公司百强排行榜”",
    "href": "http://stock.jrj.com.cn/2020/02/03000030102293.shtml",
    "datetime": "2020-02-03 00:00:00",
    "code": "300485"
  },
  {
    "title": "赛升药业：捐赠免疫调节类药物价值逾200万元",
    "href": "http://stock.jrj.com.cn/2020/02/01214828747547.shtml",
    "datetime": "2020-02-01 21:48:00",
    "code": "300485"
  },
  {
    "title": "[赛升药业]驰援湖北,共同抗“疫” ----赛升药业在行动",
    "href": "http://stock.jrj.com.cn/2020/02/01000028755300.shtml",
    "datetime": "2020-02-01 00:00:00",
    "code": "300485"
  },
  {
    "title": "赛升药业2019年度预计净利1.13亿元-1.98亿元 同比下降30%-60%",
    "href": "http://stock.jrj.com.cn/2020/01/23161528727978.shtml",
    "datetime": "2020-01-23 16:15:52",
    "code": "300485"
  },
  {
    "title": "赛升药业：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/23134028727296.shtml",
    "datetime": "2020-01-23 13:40:00",
    "code": "300485"
  },
  {
    "title": "赛升药业：公司与华大蛋白签订技术服务合同",
    "href": "http://stock.jrj.com.cn/2019/12/24220528581110.shtml",
    "datetime": "2019-12-24 22:05:34",
    "code": "300485"
  },
  {
    "title": "午间公告集锦：赛升药业与华大蛋白签订技术服务合同",
    "href": "http://stock.jrj.com.cn/2019/12/24121628578517.shtml",
    "datetime": "2019-12-24 12:16:37",
    "code": "300485"
  },
  {
    "title": "午间公告：赛升药业与华大蛋白签订技术服务合同",
    "href": "http://stock.jrj.com.cn/2019/12/24120128578501.shtml",
    "datetime": "2019-12-24 12:01:00",
    "code": "300485"
  },
  {
    "title": "赛升药业控股子公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/12/19224728559178.shtml",
    "datetime": "2019-12-19 22:47:42",
    "code": "300485"
  },
  {
    "title": "赛升药业：控股子公司一项原料药通过GMP认证 将增加公司原料药生产范围",
    "href": "http://stock.jrj.com.cn/2019/12/19174128557736.shtml",
    "datetime": "2019-12-19 17:41:12",
    "code": "300485"
  },
  {
    "title": "赛升药业：控股子公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/12/19171428557665.shtml",
    "datetime": "2019-12-19 17:14:45",
    "code": "300485"
  },
  {
    "title": "赛升药业：控股子公司获药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/12/19163628557556.shtml",
    "datetime": "2019-12-19 16:36:49",
    "code": "300485"
  },
  {
    "title": "[赛升药业]赛升药业荣登“2019年中国上市公司百强排行榜”",
    "href": "http://stock.jrj.com.cn/2019/12/12000028523472.shtml",
    "datetime": "2019-12-12 00:00:00",
    "code": "300485"
  },
  {
    "title": "[赛升药业]赛升药业荣登“2019年中国上市公司百强排行榜”",
    "href": "http://stock.jrj.com.cn/2019/12/09000028523471.shtml",
    "datetime": "2019-12-09 00:00:00",
    "code": "300485"
  },
  {
    "title": "医药板块小幅走高 赛升药业康弘药业涨停",
    "href": "http://stock.jrj.com.cn/hotstock/2019/11/14141128398870.shtml",
    "datetime": "2019-11-14 14:11:00",
    "code": "300485"
  },
  {
    "title": "赛升药业第三季度盈利3336万 同比下滑57%",
    "href": "http://stock.jrj.com.cn/2019/10/30123228324721.shtml",
    "datetime": "2019-10-30 12:32:25",
    "code": "300485"
  },
  {
    "title": "赛升药业2019前三季度净利约1.26亿-1.89亿 营业成本有所增加",
    "href": "http://stock.jrj.com.cn/2019/10/15093628247998.shtml",
    "datetime": "2019-10-15 09:36:49",
    "code": "300485"
  },
  {
    "title": "赛升药业2019年上半年净利9335万 加强市场资源整合与营销结构调整",
    "href": "http://stock.jrj.com.cn/2019/08/27000228036616.shtml",
    "datetime": "2019-08-27 00:02:35",
    "code": "300485"
  },
  {
    "title": "赛升药业：1个药品新增调入国家医保目录",
    "href": "http://stock.jrj.com.cn/2019/08/22183928018162.shtml",
    "datetime": "2019-08-22 18:39:25",
    "code": "300485"
  },
  {
    "title": "赛升药业：1个药品新增调入医保目录",
    "href": "http://stock.jrj.com.cn/2019/08/22171128017482.shtml",
    "datetime": "2019-08-22 17:11:17",
    "code": "300485"
  },
  {
    "title": "午间公告集锦：赛升药业加速创新药物布局",
    "href": "http://stock.jrj.com.cn/2019/07/24120827880942.shtml",
    "datetime": "2019-07-24 12:08:14",
    "code": "300485"
  },
  {
    "title": "午间公告：威海广泰收到业绩承诺补偿；赛升药业加速创新药物布局",
    "href": "http://stock.jrj.com.cn/2019/07/24120427880939.shtml",
    "datetime": "2019-07-24 12:04:00",
    "code": "300485"
  },
  {
    "title": "[赛升药业]赛升药业荣登2018年中国医药工业化药百强榜",
    "href": "http://stock.jrj.com.cn/2019/07/16000027848164.shtml",
    "datetime": "2019-07-16 00:00:00",
    "code": "300485"
  },
  {
    "title": "赛升药业中报净利预减30% 4年销售费同比激增10倍",
    "href": "http://stock.jrj.com.cn/2019/07/15080627839748.shtml",
    "datetime": "2019-07-15 08:06:00",
    "code": "300485"
  },
  {
    "title": "赛升药业2019年上半年净利1.32亿 受政策影响营业成本有所增加",
    "href": "http://stock.jrj.com.cn/2019/07/08222927811215.shtml",
    "datetime": "2019-07-08 22:29:42",
    "code": "300485"
  },
  {
    "title": "赛升药业：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/07/08195027810682.shtml",
    "datetime": "2019-07-08 19:50:00",
    "code": "300485"
  },
  {
    "title": "赛升药业2名股东拟减持股份 预计减持不超总股本2.8%",
    "href": "http://stock.jrj.com.cn/2019/06/19073727722964.shtml",
    "datetime": "2019-06-19 07:37:27",
    "code": "300485"
  },
  {
    "title": "赛升药业：两股东拟合计减持不超2.8%股份",
    "href": "http://stock.jrj.com.cn/2019/06/18171727720605.shtml",
    "datetime": "2019-06-18 17:17:00",
    "code": "300485"
  },
  {
    "title": "赛升药业：股东马丽和刘淑芹拟合计减持不超2.8%",
    "href": "http://stock.jrj.com.cn/2019/06/18170027720439.shtml",
    "datetime": "2019-06-18 17:00:03",
    "code": "300485"
  },
  {
    "title": "赛升药业去年净利2.83亿元 同比增长0.53% 董事长马骉年薪为83万元",
    "href": "http://stock.jrj.com.cn/2019/03/28084327256243.shtml",
    "datetime": "2019-03-28 08:43:30",
    "code": "300485"
  },
  {
    "title": "赛升药业：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/03/27181027251583.shtml",
    "datetime": "2019-03-27 18:10:00",
    "code": "300485"
  },
  {
    "title": "赛升药业：一季度净利预降0%-30%",
    "href": "http://stock.jrj.com.cn/2019/03/27180127251551.shtml",
    "datetime": "2019-03-27 18:01:45",
    "code": "300485"
  },
  {
    "title": "赛升药业：2018年净利同比增0.53% 拟10派1.2元",
    "href": "http://stock.jrj.com.cn/2019/03/27175827251500.shtml",
    "datetime": "2019-03-27 17:58:22",
    "code": "300485"
  },
  {
    "title": "赛升药业2018年净利最高3.38亿元 比上年同期下降10%",
    "href": "http://stock.jrj.com.cn/2019/01/29114226996301.shtml",
    "datetime": "2019-01-29 11:42:47",
    "code": "300485"
  },
  {
    "title": "赛升药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/28133026991388.shtml",
    "datetime": "2019-01-28 13:30:00",
    "code": "300485"
  },
  {
    "title": "[天眼]赛升药业子公司药品退出医保目录未信批收监管",
    "href": "http://stock.jrj.com.cn/2018/12/25204226801731.shtml",
    "datetime": "2018-12-25 20:42:13",
    "code": "300485"
  },
  {
    "title": "赛升药业：控股子公司土霉素片退出国家医保目录",
    "href": "http://stock.jrj.com.cn/2018/12/19164226765588.shtml",
    "datetime": "2018-12-19 16:42:58",
    "code": "300485"
  },
  {
    "title": "赛升药业：控股子公司一药品退出医保目录",
    "href": "http://stock.jrj.com.cn/2018/12/19160026765420.shtml",
    "datetime": "2018-12-19 16:00:00",
    "code": "300485"
  },
  {
    "title": "赛升药业：获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/31075925283619.shtml",
    "datetime": "2018-10-31 07:59:57",
    "code": "300485"
  },
  {
    "title": "[赛升药业]赛升药业—荣获北京民营企业“科技创新百强”及“社会责任百强”企业",
    "href": "http://stock.jrj.com.cn/2018/10/19000025253527.shtml",
    "datetime": "2018-10-19 00:00:00",
    "code": "300485"
  },
  {
    "title": "[赛升药业]我公司再次入选“2018德勤—亦庄高科技成长20强”",
    "href": "http://stock.jrj.com.cn/2018/10/12000025196366.shtml",
    "datetime": "2018-10-12 00:00:00",
    "code": "300485"
  },
  {
    "title": "赛升药业：2018年半年度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/08/16173024962495.shtml",
    "datetime": "2018-08-16 17:30:00",
    "code": "300485"
  },
  {
    "title": "[赛升药业]赛升药业荣获“第十二届中国创业板上市公司价值五十强”奖项",
    "href": "http://stock.jrj.com.cn/2018/08/15000024959965.shtml",
    "datetime": "2018-08-15 00:00:00",
    "code": "300485"
  },
  {
    "title": "赛升药业：拟推480万股限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2018/08/03175524903058.shtml",
    "datetime": "2018-08-03 17:55:00",
    "code": "300485"
  },
  {
    "title": "赛升药业：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/07/12194024806986.shtml",
    "datetime": "2018-07-12 19:40:00",
    "code": "300485"
  },
  {
    "title": "赛升药业：关于首次公开发行前已发行股份上市流通的提示性公告",
    "href": "http://stock.jrj.com.cn/2018/06/21211024711938.shtml",
    "datetime": "2018-06-21 21:10:00",
    "code": "300485"
  },
  {
    "title": "赛升药业：近2100万限售股6月27日解禁上市流通",
    "href": "http://stock.jrj.com.cn/2018/06/21202024711808.shtml",
    "datetime": "2018-06-21 20:20:00",
    "code": "300485"
  },
  {
    "title": "赛升药业：目前进口抗癌药物零关税政策对经营未产生影响",
    "href": "http://stock.jrj.com.cn/2018/04/16093024393510.shtml",
    "datetime": "2018-04-16 09:30:00",
    "code": "300485"
  },
  {
    "title": "周末年报高送转:赛升药业年报拟10转10派2.4元",
    "href": "http://stock.jrj.com.cn/2018/03/12083524225037.shtml",
    "datetime": "2018-03-12 08:35:25",
    "code": "300485"
  },
  {
    "title": "赛升药业：年报拟10转10派2.4元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/03/12075924224808.shtml",
    "datetime": "2018-03-12 07:59:59",
    "code": "300485"
  },
  {
    "title": "赛升药业：2017年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/01/19170023975278.shtml",
    "datetime": "2018-01-19 17:00:05",
    "code": "300485"
  },
  {
    "title": "[赛升药业]赛升药业董事长马骉2017天府金融论坛--聚焦专访",
    "href": "http://stock.jrj.com.cn/2017/11/29000023715115.shtml",
    "datetime": "2017-11-29 00:00:00",
    "code": "300485"
  },
  {
    "title": "[赛升药业]献爱心,传温暖--一封特殊的来信",
    "href": "http://stock.jrj.com.cn/2017/09/28000024476476.shtml",
    "datetime": "2017-09-28 00:00:00",
    "code": "300485"
  },
  {
    "title": "[赛升药业]赛升药业携手华大蛋白驶出蛋白质多肽药物研发新速度",
    "href": "http://stock.jrj.com.cn/2017/09/12000024476475.shtml",
    "datetime": "2017-09-12 00:00:00",
    "code": "300485"
  },
  {
    "title": "[赛升药业]赛升药业荣获“中国创业板上市公司价值五十强”称号",
    "href": "http://stock.jrj.com.cn/2017/08/24000024476473.shtml",
    "datetime": "2017-08-24 00:00:00",
    "code": "300485"
  },
  {
    "title": "[赛升药业]赛升药业捐资助学圆梦行动 ——走进公主岭市河南街道阳光社区",
    "href": "http://stock.jrj.com.cn/2017/08/24000024476474.shtml",
    "datetime": "2017-08-24 00:00:00",
    "code": "300485"
  },
  {
    "title": "[赛升药业]珍爱生命 从我做起——北京赛升药业股份有限公司红十字会应急救护培训",
    "href": "http://stock.jrj.com.cn/2017/08/14000024476472.shtml",
    "datetime": "2017-08-14 00:00:00",
    "code": "300485"
  },
  {
    "title": "赛升药业拟参与竞拍华大蛋白45%股权",
    "href": "http://stock.jrj.com.cn/2017/06/14130622608098.shtml",
    "datetime": "2017-06-14 13:06:00",
    "code": "300485"
  },
  {
    "title": "[赛升药业]赛升药业公益行——走进北京首儿李桥儿童医院",
    "href": "http://stock.jrj.com.cn/2017/05/27000024476471.shtml",
    "datetime": "2017-05-27 00:00:00",
    "code": "300485"
  },
  {
    "title": "[赛升药业]赛升药业荣登福布斯“2017中国上市公司潜力企业榜”",
    "href": "http://stock.jrj.com.cn/2017/05/19000024476470.shtml",
    "datetime": "2017-05-19 00:00:00",
    "code": "300485"
  },
  {
    "title": "赛升药业控股子公司收到环保部门行政处罚",
    "href": "http://stock.jrj.com.cn/2016/08/17155821330969.shtml",
    "datetime": "2016-08-17 15:58:46",
    "code": "300485"
  },
  {
    "title": "赛升药业斥千万购1.1类肿瘤新药批件",
    "href": "http://stock.jrj.com.cn/2015/10/27124819987154.shtml",
    "datetime": "2015-10-27 12:48:36",
    "code": "300485"
  },
  {
    "title": "赛升药业等3只新股公布网上中签率",
    "href": "http://stock.jrj.com.cn/2015/06/18195219377288.shtml",
    "datetime": "2015-06-18 19:52:04",
    "code": "300485"
  },
  {
    "title": "赛升药业预披露更新 拟发行不超过3000万股",
    "href": "http://stock.jrj.com.cn/2015/05/07192319195616.shtml",
    "datetime": "2015-05-07 19:23:38",
    "code": "300485"
  },
  {
    "title": "赛升药业：A股IPO已在环保核查",
    "href": "http://stock.jrj.com.cn/ipo/2012/10/19091414539578.shtml",
    "datetime": "2012-10-19 09:14:24",
    "code": "300485"
  }
]